Davis Blaine

Chief Financial Officer at RNAC

Sold, on record
$206k
Dollars the filings state
Form 4 sales
2
Latest Jan 6, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • RNACCartesian Therapeutics, Inc.Chief Financial Officer

Sales by reason

0
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale RNACNo plan
    Jan 6, 2025 2025

    Sold 7,989 shares at $16.78 ($134k)

    Davis Blaine, Chief Financial Officer

    No 10b5-1 planSold 7.8% of holdings ($1.7M position)94,811 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale RNACNo plan
    Jan 6, 2026 +365 days

    Sold 10,591 shares at $6.82 ($72k)

    Davis Blaine, Chief Financial Officer

    No 10b5-1 planSold 8% of holdings ($899k position)121,220 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Davis Blaine
Source
Jan 6, 2026Jan 8, 2026RNACChief Financial OfficerForm 4 sale10,591$72k8.0%No planSEC
Jan 6, 2025Jan 7, 2025RNACChief Financial OfficerForm 4 sale7,989$134k7.8%No planSEC